- Home
- PDSB vs UCL Comparison
PDSB vs UCL Comparison
Compare PDSB & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- UCL
- Stock Information
- Founded
- PDSB 2005
- UCL 2014
- Country
- PDSB United States
- UCL Hong Kong
- Employees
- PDSB N/A
- UCL N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- PDSB Health Care
- UCL Consumer Discretionary
- Exchange
- PDSB Nasdaq
- UCL Nasdaq
- Market Cap
- PDSB 58.7M
- UCL 49.7M
- IPO Year
- PDSB N/A
- UCL 2020
- Fundamental
- Price
- PDSB $1.34
- UCL $1.25
- Analyst Decision
- PDSB Strong Buy
- UCL
- Analyst Count
- PDSB 3
- UCL 0
- Target Price
- PDSB $14.00
- UCL N/A
- AVG Volume (30 Days)
- PDSB 235.1K
- UCL 95.5K
- Earning Date
- PDSB 03-26-2025
- UCL 03-13-2025
- Dividend Yield
- PDSB N/A
- UCL N/A
- EPS Growth
- PDSB N/A
- UCL 169.91
- EPS
- PDSB N/A
- UCL 0.11
- Revenue
- PDSB N/A
- UCL $87,405,000.00
- Revenue This Year
- PDSB N/A
- UCL $7.21
- Revenue Next Year
- PDSB N/A
- UCL $15.05
- P/E Ratio
- PDSB N/A
- UCL $11.19
- Revenue Growth
- PDSB N/A
- UCL 4.73
- 52 Week Low
- PDSB $1.25
- UCL $0.97
- 52 Week High
- PDSB $6.68
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- PDSB 40.27
- UCL 42.69
- Support Level
- PDSB $1.41
- UCL $1.17
- Resistance Level
- PDSB $1.56
- UCL $1.31
- Average True Range (ATR)
- PDSB 0.14
- UCL 0.09
- MACD
- PDSB -0.00
- UCL 0.01
- Stochastic Oscillator
- PDSB 21.24
- UCL 32.54
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.